Patients with CARD9 deficiency are susceptible to invasive fungal diseases and chronic mucocutaneous candidiasis (CMC) as a result of primary immune dysfunction (9, 10). This evidence concerns the gene CARD9 and Chronic mucocutaneous candidosis.